The Journal of Practical Medicine ›› 2021, Vol. 37 ›› Issue (5): 569-573.doi: 10.3969/j.issn.1006⁃5725.2021.05.003

• Clinical Advances • Previous Articles     Next Articles

Research progress in bisphosphonates for treatment of primary osteoporosis

LI Yiyu,GUAN Yaxin,WU Bin   

  1. Department of Endocrinology,the First Affiliated Hospital of Kunming Medical University,Kunming 650032,China 

  • Online:2021-03-10 Published:2021-03-10
  • Contact: WU Bin E⁃mail:wu.bin.kmu@qq.com

Abstract:

Osteoporosis is a systemic metabolic disease. Bisphosphonates are the first ⁃line drugs in the treatment of osteoporosis,which have been proved to have significant effects on improving bone density and reduc⁃ ing the risk of fracture. This article systematically reviewed the mechanism of action,clinical efficacy,adverse reactions and drug holiday of several bisphosphonates,which might provide useful information for future research.

Key words:

bisphosphonates, osteoporosis, clinical efficacy, adverse reactions, drug holiday